July, 2025

article thumbnail

Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

article thumbnail

Early Detection to Expert Dosing: The Pharmacist’s Clinical Role in TD Management

Pharmacy Times

Panelists discuss how pharmacists, through frequent patient contact and vigilant observation, are uniquely positioned to identify early signs of tardive dyskinesia, conduct AIMS assessments, monitor treatment efficacy, foster patient trust, and provide crucial education to support timely intervention and improve long-term management outcomes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How the NHS 10-year plan will affect pharmacy

Hospital Pharmacy Europe

The NHS 10-year plan will see pharmacists among the staff leading the Government’s new neighbourhood health centres, the Prime Minister has announced. This will reduce pressure and demand on hospitals and allow secondary care teams to focus on specialist care supported by technology to improve productivity. Sir Keir Starmer set out the details of the highly anticipated 10-year plan for the NHS – largely focusing on the Government’s ambitions for a Neighbourhood Health Service.

article thumbnail

How Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pharma Horizons: leading-edge formulation

European Pharmaceutical Review

Numerous types of formulations can be used to create pharmaceuticals, such as solid dosage forms, liquid dispersions, gel through to creams. Drug development professionals should consider relevant factors including the intended patients and application, properties of the raw materials and more. As such, those working in the sector must maintain awareness of the latest developments to optimise processes, ensure compliance and that a safe, high-quality product is produced.

article thumbnail

7 proven strategies to build a pharmacist-patient relationship

The Checkup by Singlecare

Pharmacists do a lot more than just count pills behind the counter. They’re important healthcare professionals who can greatly influence how patients take care of their health. Building strong relationships with patients not only helps with medication adherence but also makes work more rewarding for pharmacists. Creating meaningful relationships doesn’t have to take a lot of time, even for pharmacists with busy schedules.

More Trending

article thumbnail

FDA Approves Zoster Vaccine Recombinant Prefilled Syringe Presentation for Shingles Prevention

Pharmacy Times

The FDA approves a prefilled syringe for the zoster vaccine recombinant, enhancing shingles vaccination convenience and effectiveness for adults 50 and older.

article thumbnail

Strategies for digital success in hospital pharmacy

Hospital Pharmacy Europe

With the impact of digital technologies on healthcare provision and the workforce ramping up, Matthew Spence, clinical digital lead for medicines management and pharmacy services at Leeds Teaching Hospitals NHS Trust, offers practical tips and strategies based on insights and initiatives from his own hospital to support pharmacy teams in navigating digital transformation.

article thumbnail

Pricing watchdog will take on the rising cost of drugs at launch

PharmaVoice

ICER’s upcoming report could shed light on how the launch price of newly approved drugs affects overall cost and access from a patient perspective.

article thumbnail

World-first legislation backs decentralised manufacturing

European Pharmaceutical Review

New regulation enforced by the Medicines and Healthcare products Regulatory Agency (MHRA), means the UK is the first country to introduce a legal framework enabling cutting-edge personalised medicines to be manufactured at point of care. These therapies, such as CAR-T cancer therapy, have previously been produced in specialist facilities often far away from patients, resulting in treatment delays.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Ovagen breakthrough boosts yellow fever vaccine yields

Pharma Times

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Ovagen breakthrough boosts yellow fever vaccine yields by John Pinching | 23rd Jul 2025 | News Irish biotech’s germ-free egg platform could help close global shortfall Irish biotech Ovagen has announced a major advance in vaccine manufacturing, with new data showing its germ-free embryonated eggs can produce

article thumbnail

Pneumococcal Vaccine Patient Education: What Pharmacists Should Know and Share

Drug Topics

Panelists discuss how pharmacists should educate patients about pneumococcal vaccines by providing current vaccine information statements (VIS) updated May 29, 2025, explaining common adverse effects like injection site reactions and mild systemic symptoms as normal immune responses, conducting thorough pre-vaccination screening for moderate-to-severe illness, allergies to vaccine components (noting that conjugated vaccines contain yeast), and history of fainting or anxiety, while emphasizing th

article thumbnail

AACP 2025: From Research to Action on Representation Gaps in Pharmacy Education

Pharmacy Times

Omolola (Lola) Adeoye-Olatunde, PharmD, MS, discusses findings from a multi-year analysis of American Association of Colleges of Pharmacy (AACP) institutional data on faculty and graduate student representation in pharmacy education, highlighting persistent disparities and offering actionable strategies to improve equity and inclusion in the academic pipeline.

article thumbnail

Social Media Analytics: What’s Important in Modern Marketing?

Pharma Marketing Network

Imagine trying to navigate a busy city without a GPS. That’s how modern pharma marketing would feel without social media analytics. In an era where every scroll, like, and comment reveals intent, understanding and measuring digital interactions is no longer optional—it’s mission-critical. As pharmaceutical marketers seek better ways to personalize content, boost ROI, and remain compliant, social media analytics emerges as the compass guiding informed decisions.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

PBMs, not patents, are blocking access to lower-cost medicines

PhRMA

Since 2014, the three largest pharmacy benefit managers (PBMs) have excluded 1,584% more medicines from commercial formularies, according to a new report from Cencora. Formularies are the lists of medicines covered in commercial health plans, often organized into tiers. The report highlights a concerning trend: the average annual increase in medications being excluded from formularies was 27%.

article thumbnail

What will shape the Pharma landscape in Q3 2025?

European Pharmaceutical Review

The upcoming financial quarter for the pharmaceutical industry is set to see changes driven by “innovation, competitive positioning, and regulatory momentum”, according to a report by GlobalData. Key influences include late-stage clinical trial results and regulatory decisions by the US Food and Drug Administration (FDA). In the current quarter, the US agency approved the first new on-demand treatment for hereditary angioedema (HAE) in over a decade.

article thumbnail

3 major patent losses this year — and a key strategy to fill the gaps

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

FDA
article thumbnail

Pharmacist’s Guide: Choosing the Most Appropriate Pneumococcal Vaccine for Patients

Drug Topics

Panelists discuss how pharmacists should ensure patients receive at least one conjugated pneumococcal vaccine (PCV-15, PCV-20, or PCV-21) as the foundation of protection, with subsequent vaccine sequencing depending on which initial vaccine was given—where PCV-15 recipients should receive PPSV-23 one year later for additional serotype coverage, patients with prior PCV-13 need PCV-20 or PCV-21 after a one-year interval, and immunocompromised patients or those with cochlear implants/CSF leaks can

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Expert: Lenacapavir Shows 100% Efficacy in Key Trial, Offering Transformative Twice-Yearly HIV Prevention

Pharmacy Times

Namrata Shah, MD, discusses the groundbreaking efficacy and patient-centered potential of twice-yearly lenacapavir for HIV pre-exposure prophylaxis (PrEP), supported by pivotal data from the PURPOSE trials.

article thumbnail

SMC recommends Eladynos for postmenopausal osteoporosis in Scotland

Pharmafile

Theramex, a women’s health pharma company, has announced that the Scottish Medicines Consortium has recommended Eladynos (abaloparatide) for NHS use in Scotland. This offers a new treatment option for postmenopausal women at high risk of fracture. Osteoporosis is a progressive condition causing fragile bones and fractures. Hip fractures alone are responsible for around 50% of […] The post SMC recommends Eladynos for postmenopausal osteoporosis in Scotland appeared first on Pharmafile.

article thumbnail

FDA Softens August 2025 NDSRI Deadline—Progress Reports Now Accepted

The FDA Law Blog

By Charles D. Snow — Recently, FDA announced a deadline shift, although the Agency did so quietly. On June 23, 2025, FDA updated its CDER Nitrosamine Impurity Acceptable Intake Limits webpage to permit manufacturers and sponsors more time to submit required changes for nitrosamine drug substance‑related impurities (NDSRIs) for approved or currently marketed products.

FDA
article thumbnail

Sanofi $1.6 billion acquisition to advance respiratory vaccines

European Pharmaceutical Review

Sanofi has agreed to acquire the biotech Vicebio for an upfront payment of $1.15 billion, supporting the advancement of respiratory virus vaccines. In addition to the initial payment, Sanofi will pay up to $450 million, subject to achieved development and regulatory milestones. The deal intends to expand capabilities in vaccine design and development and will enable Sanofi to add a non-mRNA vaccine to its development pipeline.

article thumbnail

Pharma News Stories You Should Be Following

Pharma Marketing Network

The pharmaceutical world never sleeps. From FDA approvals to policy shifts and AI-driven innovations, every week brings changes that could redefine patient outcomes and market strategies. But how do you know which pharma news stories matter most? Think of the industry as a fast-moving river—keeping up means knowing where the currents are headed. In this article, we spotlight critical pharmaceutical developments, innovations, and marketing trends you need to monitor to stay competitive.

FDA
article thumbnail

Collaborative, Pharmacist-Led Approach Crucial in Polypharmacy

Drug Topics

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

article thumbnail

How Pharmacists Can Strengthen Completion of Vaccine Series

Pharmacy Times

An expert discusses how pharmacists can ensure completion of multidose pneumococcal vaccine series through electronic reminder systems, state immunization registries, scheduled follow-up appointments, and providing patients with printed vaccine cards for tracking purposes.

article thumbnail

From ward manipulations to 3D printing: shaping the future of personalised medication

Hospital Pharmacy Europe

As demand for personalised treatments grows, 3D printing is transforming pharmaceutical development with unmatched precision and adaptability. This shift away from ward-based manipulations of medication is especially vital in paediatrics, where accurate dosing and child-friendly formulations are crucial for safe and effective care, as Mattias Paulsson explains.

article thumbnail

Top 5 DOAC Drug Interactions

Med Ed 101

Direct oral anticoagulants (DOACs) are widely used in a variety of conditions, including atrial fibrillation, pulmonary embolism, and deep vein thrombosis. Most DOACs are metabolized by CYP3A4 and utilize the P-glycoprotein (P-gp) transporter. Thus, common interactions include medications that are involved with CYP3A4 and P-gp. Below are my top five most important DOAC drug interactions […] The post Top 5 DOAC Drug Interactions appeared first on Med Ed 101.

article thumbnail

Breaking down silos – how digital tools can transform pharma manufacturing

European Pharmaceutical Review

New research reveals that while 52 percent of pharmaceutical companies remain in early stages of digitalisation, leading manufacturers are finding innovative ways to overcome data fragmentation and drive operational efficiency. The pharmaceutical manufacturing sector stands at a digital crossroads. Despite significant investment in modern technologies, more than half of companies are still struggling with the fundamentals of digitalisation, according to recent research conducted by Hexagon in pa

article thumbnail

The Importance of High Impact Sponsorships in Pharma Marketing

Pharma Marketing Network

Pharmaceutical marketing has evolved far beyond traditional advertising. In a digital-first and HCP-centric world, high impact sponsorships are emerging as a cornerstone strategy for brands aiming to cut through the noise and establish authentic, memorable engagement. But how do these sponsorships deliver superior value compared to other channels? Imagine a specialist at a major medical conference pausing at your branded pavilion—not just to grab a tote bag, but to engage in real-time learning,

article thumbnail

2023-2024 COVID-19 Vaccine Efficacy Wanes Over Time

Drug Topics

A new study reveals the waning effectiveness of 2023-2024 COVID-19 vaccines, highlighting the need for ongoing vaccinations and pharmacist involvement.

article thumbnail

Pharmacists Practicing at the Top of Their Training in Managing Tardive Dyskinesia

Pharmacy Times

Panelists discuss how pharmacists play a vital role in managing tardive dyskinesia by conducting regular AIMS assessments, supporting medication adherence and tolerability, collaborating with health care teams, and integrating standardized monitoring into clinical workflows to enable early detection and optimize patient outcomes across care settings.

article thumbnail

England to have single national formulary within two years

Hospital Pharmacy Europe

A single national formulary (SNF) for prescribing in England will be in place within the next two years under proposals, the Government has announced. Outlined in the new NHS 10-year plan and backed by the National Institute for Health and Care Excellence (NICE), the SNF will reduce duplication and the ‘postcode lottery’ that has arisen out of locally derived formularies, the Government said.

article thumbnail

A biopharma doubles down on diversity goals through a newly created position

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

FDA